Citigroup
GOSS icon

Citigroup’s Gossamer Bio GOSS Stock Holding History

Citigroup’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Sell
82
-140
-63% -$3.13K ﹤0.01% 5406
2026
Q1 		$5.83K Sell
222
-393
-64% -$49.4K ﹤0.01% 5220
2025
Q4 		$153K Buy
615
+240
+64% +$54.8K ﹤0.01% 4119
2025
Q3 		$78.9K Sell
375
-468
-56% -$82.5K ﹤0.01% 4346
2025
Q2 		$82.9K Buy
843
+710
+534% +$62K ﹤0.01% 4502
2025
Q1 		$11.7K Buy
+133
New +$12.3K ﹤0.01% 5168
2024
Q4 		– Sell
-8,223
Closed -$564K – 5793
2024
Q3 		$649K Buy
8,223
+1,973
+32% +$152K ﹤0.01% 3564
2024
Q2 		$450K Sell
6,250
-22,347
-78% -$1.34M ﹤0.01% 3465
2024
Q1 		$2.7M Buy
28,597
+7,279
+34% +$641K ﹤0.01% 2186
2023
Q4 		$1.56M Buy
21,318
+18,859
+767% +$1.11M ﹤0.01% 2456
2023
Q3 		$164K Buy
2,459
+2,434
+9,736% +$224K ﹤0.01% 3755
2023
Q2 		$2.36K Buy
25
+7
+39% +$697 ﹤0.01% 5268
2023
Q1 		$1.76K Sell
18
-15,051
-100% -$2.3M ﹤0.01% 5105
2022
Q4 		$2.62M Buy
15,069
+1,630
+12% +$1.07M ﹤0.01% 1847
2022
Q3 		$12.9M Buy
13,439
+2,504
+23% +$2.49M 0.01% 1014
2022
Q2 		$7.32M Buy
10,935
+10,105
+1,217% +$6.26M 0.01% 1309
2022
Q1 		$576K Sell
830
-1,080
-57% -$833K ﹤0.01% 3414
2021
Q4 		$1.73M Sell
1,910
-400
-17% -$380K ﹤0.01% 2741
2021
Q3 		$2.32M Buy
2,310
+84
+4% +$61.9K ﹤0.01% 2417
2021
Q2 		$1.45M Sell
2,226
-494
-18% -$343K ﹤0.01% 2939
2021
Q1 		$2.01M Buy
2,720
+2,501
+1,142% +$2.02M ﹤0.01% 2480
2020
Q4 		$170K Buy
219
+136
+164% +$107K ﹤0.01% 5111
2020
Q3 		$83K Sell
83
-375
-82% -$398K ﹤0.01% 5254
2020
Q2 		$476K Buy
458
+14
+3% +$14.1K ﹤0.01% 4308
2020
Q1 		$361K Sell
444
-41
-8% -$42.8K ﹤0.01% 4186
2019
Q4 		$607K Buy
485
+460
+1,840% +$741K ﹤0.01% 4250
2019
Q3 		$33K Sell
25
-53
-68% -$84.3K ﹤0.01% 6401
2019
Q2 		$140K Buy
78
+40
+105% +$61.2K ﹤0.01% 5568
2019
Q1 		$66K Buy
+38
New +$63.4K ﹤0.01% 6105

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Citigroup's GOSS Position: Q2 2026 in Review

Citigroup reduced its Gossamer Bio (GOSS) stake by 63% in Q2 2026, selling an estimated $3.13K and leaving 82 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5406.

Citigroup first reported a position in GOSS in Q1 2019 and has held it in 29 quarters since. The position peaked at $12.9M in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Citigroup held 82 shares of Gossamer Bio worth $1.08K as of Q2 2026.
  • Citigroup sold 140 Gossamer Bio shares in Q2 2026, an estimated $3.13K.
  • Gossamer Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5406 holding.
  • Citigroup first reported a position in Gossamer Bio in Q1 2019 and has held it in 29 quarters since.
  • Citigroup's Gossamer Bio position peaked at $12.9M in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.